NASDAQ:IBB
iShares Nasdaq Biotechnology Index Fund ETF News
$132.96
+2.31 (+1.77%)
At Close: May 03, 2024
5 Least-Hurt Biotech ETFs of the Last Week
02:18pm, Wednesday, 15'th Feb 2023
Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
Pharmaceutical companies losing patent protection as competition grows
03:34pm, Thursday, 09'th Feb 2023
The Wall Street Journal's Jared Hopkins joins 'Power Lunch' to discuss biotech patent protection duration, competition coming to the pharmaceutical industry and pharmaceutical M&A plans.
There's a crop of great biotech companies ready to be acquired, says MPM's Christiana Bardon
03:15pm, Thursday, 02'nd Feb 2023
Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins 'The Exchange' to discuss tailwinds in the pharmaceutical and biotech sector, innovation in obesity drugs, and acquisition
Biotech Stocks Reward Shareholders Who Handle The Bumpy Ride
02:56pm, Friday, 27'th Jan 2023
Biotech and medical device stocks can be highly profitable. One of these volatile issues just catapulted over 41%.
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:32am, Tuesday, 17'th Jan 2023
Smart Beta ETF report for IBB
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:32am, Wednesday, 11'th Jan 2023
Sector ETF report for IBB
Subversive Launches ETF to Focus on Mental Health
08:11pm, Tuesday, 03'rd Jan 2023
The debut highlights the lack of funds focused on the area.
Biotech is Set for a Blockbuster 2023: Here's Why
11:17am, Friday, 23'rd Dec 2022
The biotech sector has been outperforming the major U.S. indices for the past few months. Can the strength continue?
Biotech Stock Finds Favor Amongst Mutual Fund Managers
10:09am, Friday, 23'rd Dec 2022
A hyper-bullish breakaway gap supports positive price action in this leading biotech stock. The post Biotech Stock Finds Favor Amongst Mutual Fund Managers appeared first on Investor's Business Daily.
4 Market-Beating Top Sector ETFs of Q4 to Buy Now
09:02am, Wednesday, 21'st Dec 2022
These four top-ranked sector ETFs topped the market in the ongoing fourth quarter.
JPMorgan's bullish call on biopharma
02:12pm, Friday, 16'th Dec 2022
The "Halftime Report" traders debate the biggest analyst calls of the day.
IBB: Shares Breaking Out With A Still-Reasonable Valuation
06:20pm, Friday, 02'nd Dec 2022
Biotech stocks, while a volatile spot of the broad U.S. market, look good from a risk/reward point of view. IBB's valuation is reasonable relative to history while the technical chart sports a bullish
Final Trades: IBB, META, TSM & LVS
06:11pm, Friday, 02'nd Dec 2022
The traders make their final trades of the week. With CNBC's Dominic Chu and the Fast Money traders, Tim Seymour, Courtney Garcia, Steve Grasso and Jeff Mills.
ETFs Find a Role in a Long-Term Portfolio
12:01pm, Tuesday, 29'th Nov 2022
Albion Financial's Jason Ware sees funds as mainstays in ‘core-satellite' planning.
